President & CEO
NanoMedical Systems, Inc.
Randy Goodall received his BS and PhD in Physics from Caltech and the University of Oregon, respectively. Randy joined ADE in Boston, Massachusetts in 1987 to lead the Software and Systems Technology groups in developing next generation micro- and nano-scale measurement technologies, system architectures, and computational algorithms.
In early 1994, Randy joined SEMATECH as a Senior Member of Technical Staff, where he directed factory productivity technology programs. On special assignment to the CEO, Randy was the first Director of the SEMATECH External Programs office and developed several hundred million dollars in leveraged R&D funding. In a special project, he led 10 large oil companies to agree to the formation of a nanotechnology R&D consortium. In 2006, Randy headed the $4M NanoScholar university internship program.
In late 2007, Dr. Goodall left SEMATECH to co-found NanoMedical Systems. Randy is President and CEO of this Texas startup company, which is commercializing a revolutionary drug delivery technology. The company has raised $8 million. Dr. Goodall has published dozens of papers on silicon wafer technology, R&D collaboration and consortia, industry technology transitions, convergence, and productivity modeling. In addition, Goodall has spoken to and/or co-authored a number of technology-economics white papers for state governments, DARPA, Defense Science Board, US House Science Committee, and members of the President’s Counsel of Advisors on Science & Technology.